Stocks•5 November 2026•
1 min read
Ovid Therapeutics and TMC Schedule Q3 2026 Earnings Announcements
Key Facts
1Ovid Therapeutics scheduled its third quarter 2026 financial results release for November 11, 2026.
2TMC the metals company Inc. scheduled a conference call for November 12, 2026, to discuss Q3 results and corporate updates.
Ovid Therapeutics scheduled its third quarter 2026 financial results release for November 11, 2026. According to Benzinga, TMC the metals company Inc. will also host a conference call on November 12, 2026, to discuss its Q3 results and provide corporate updates.
Ovid Therapeutics (OVID) closed at $2.74 on November 4, 2026, having traded between a day low of $2.38 and a high of $2.79. On the same day, TMC closed at $2.31, with its session range spanning from $2.27 to $2.41.